These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Neuroendocrine function in Huntington's disease: dopaminergic regulation of prolactin release. Caine E; Kartzinel R; Ebert M; Carter AC Life Sci; 1978 Mar; 22(10):911-8. PubMed ID: 147978 [No Abstract] [Full Text] [Related]
48. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)]. Schlienger JL; Kapfer MT; Singer L; Stephan F Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002 [TBL] [Abstract][Full Text] [Related]
49. Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion. Rau H; Althoff PH; Schmidt K; Usadel KH Acta Endocrinol (Copenh); 1992 Mar; 126(3):247-52. PubMed ID: 1574954 [TBL] [Abstract][Full Text] [Related]
50. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease. Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607 [TBL] [Abstract][Full Text] [Related]
51. Serum thyrotrophin, prolactin and growth hormone, response to TRH during oestrogen treatment. Rutlin E; Haug E; Torjesen PA Acta Endocrinol (Copenh); 1977 Jan; 84(1):23-35. PubMed ID: 401551 [TBL] [Abstract][Full Text] [Related]
52. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly. Hanew K; Sasaki A; Mouri T; Yoshinaga K Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756 [No Abstract] [Full Text] [Related]
59. Lisuride in parkinsonism. Parkes JD; Schachter M; Marsden CD; Smith B; Wilson A Ann Neurol; 1981 Jan; 9(1):48-52. PubMed ID: 7212665 [TBL] [Abstract][Full Text] [Related]
60. Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG; Cozzi R; Chiodini P; Luccarelli G N Engl J Med; 1985 Sep; 313(11):656-9. PubMed ID: 4022058 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]